PharmaLogic to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

September 2, 2024

BOCA RATON, FL., September 2,2024 -- PharmaLogic Holdings, Inc. (“PharmaLogic”), the leading independent contract development and manufacturing organization (CDMO)specialized in radiopharmaceuticals, announced Etienne Montagut, President, will present at the Morgan Stanley 22^nd Annual Global Healthcare Conference at 7:00 a.m. ET on Friday, September 6.

About PharmaLogic Holdings Corp.

PharmaLogic is the leading independent contract development and manufacturing organization (CDMO) specialized in novel diagnostic and therapeutic radiopharmaceuticals used for the treatment of cancers, neurodegenerative conditions and other diseases. In addition to best-in-class infrastructure in North America, PharmaLogic has decades of expertise in supporting Pharmaceutical Companies with modular manufacturing, end-to-end distribution, and related development services. For more information, visit: www.radiopharmacy.com.

‍